Good performers after being hired are formed using the Roche mold and after a few years they become average or worse.
They will take this new normal with them when they change employment.
With closing manufacturing the company has become a large aimless research place following the requests from Roche. Its executives are unable to make independent decisions
Lost connection to manufacturing. The management decided to close the manufacturing plants. It has become a place doing often irrelevant work for the parent company. It has been also a source of personnel for smaller companies with disappointing results. These people taken out of their niches lack perspective of broad aspects of drug development process.
Would be nice to be big pharma, but with ultrarare diseases no way.
Alex H. has already a list of persons in upper management to be replaced. Will bring in some from Genentech. Not good for the company since there they do what Roche tells them to do. No experience in independent drug discovery, development and bringing to market.
They will take positions and start replacing us with people from Genentech.
Check whether your superior is on this replacement list. If she goes, you will go.
